Hepatitis C Treatment - Investors Hub - PEREGRINE PHARMACEUTICALS (PPHM)Post #3555

Investors Hub - PEREGRINE PHARMACEUTICALS (PPHM)Post #3555
Peregrine Announces Acceleration of Its Tarvacin Anti-Viral Hepatitis C Clinical Program - Patient Enrollment and Dosing in Initial Phase I Trial Now Scheduled for Completion in February Prelim

The medical treatment of acute hepatitis C viral infection by
and jaundice in this phase of acute viral hepatitis C (acute VHC). Clinical symptoms are not difference with other types of hepatitis. Hepatitis C is weighty disease although its acute phase have

VoyForums: Hepatitis C Outreach Project
Chronic viral hepatitis C: management update KS Gutfreund, VG Bain CMAJ 2000;162(6):827-33 Wed, August 15 2001, 8:27:35 PDT PREVENTIVE CARE IN CHRONIC LIVER DISEASE -- Riley TR, Smith JP (J Gen Intern